Impact ledger
Staar Surgical Company (STAA): the developments shaping its investment case
Follow the evidence affecting Staar Surgical Company. Review the key developments below. Continue in Market Ontology to test your assumptions, examine related opportunities, and save the investment case you want to track.
Research Staar Surgical Company · $399/mo
Test assumptions, examine opportunities, and save your research.
Material developments
2026-09-27 · 6 reports
Staar Surgical Board Authorizes $50 Million Share Buyback Program
Channel: Direct capital allocation decision signaling management confidence and returning capital to shareholders.
Bullish· 1-3m
2026-09-27
Staar Surgical initiates $50M share repurchase program, lifting stock 7.5%
Channel: Direct capital allocation decision, signaling management confidence and returning capital to shareholders.
Bullish· 1-3m
Event impact log
7 events mapped to STAA since 2026-09-26. Evidence through 2026-09-27.
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-09-27 | Staar Surgical Board Authorizes $50 Million Share Buyback Program | Direct capital allocation decision signaling management confidence and returning capital to shareholders. | Bullish | 1-3m | 0.80 |
| 2026-09-27 | Staar Surgical initiates $50M share repurchase program, lifting stock 7.5% | Direct capital allocation decision, signaling management confidence and returning capital to shareholders. | Bullish | 1-3m | 0.80 |
| 2026-09-27 | Staar Surgical Board Authorizes $50 Million Share Repurchase Program | Direct capital allocation decision signaling management confidence and returning capital to shareholders. | Bullish | 1-3m | 0.80 |
| 2026-09-27 | Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program | Direct capital allocation decision signaling management confidence and potentially reducing share count. | Bullish | 1-3m | 0.80 |
| 2026-09-26 | Staar Surgical Board Approves $50 Million Share Repurchase Program | Direct capital allocation decision signaling management confidence and returning capital to shareholders. | Bullish | 1-3m | 0.70 |
| 2026-09-26 | Staar Surgical authorizes $50M share repurchase program | Direct capital allocation decision signaling management confidence and returning capital to shareholders. Reduces share count, potentially boosting EPS. | Bullish | 1-3m | 0.80 |
| 2026-09-26 | Staar Surgical Board Authorizes $50M Share Repurchase Program | Direct capital allocation decision signaling management confidence and returning capital to shareholders. Reduces share count, increasing EPS. | Bullish | 1-3m | 0.70 |
Continue this research
Build your Staar Surgical Company investment case. Continue from the evidence above, change the assumptions the developments move, and save the work to revisit as the case develops.
This ledger is regenerated from Market Ontology's public event pipeline. View the STAA entity page →